SANDOZ PRIVATE LTD

Overview

SANDOZ PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering CLOFAZIMINE.

API / Drug Master Files

SANDOZ PRIVATE LTD holds 1 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CLOFAZIMINEActive2003-06-26
• MEROPENEM WITH SODIUM CARBONATE, STERILE BLENDInactive2014-01-17
• MEROPENEM TRIHYDRATE, STERILEInactive2014-01-08
• DORIPENEM MONOHYDRATE, STERILEInactive2011-10-10
• LANSOPROZOLEInactive2011-06-13
• IMIPENEN STERILEInactive2009-11-25
• IMIPENEM AND CILASTATIN STERILE BLENDInactive2009-11-24
• ESCITALOPRAM OXALATEInactive2009-05-05
• ROSIGLITAZONE MALEATEInactive2006-10-23
• CEFPROZILInactive2004-06-07
• CEFPODOXIME PROXETILInactive2003-04-15
• CEFIXIMEInactive2002-12-17
• CEFUROXIME AXETILInactive2002-01-21
• PYRILAMINE MALEATE USPInactive1998-03-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SANDOZ PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.